Metropolitan Life Insurance Company (MetLife)’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding BCEL
BBA
RG
EC
BC
GF
Metropolitan Life Insurance Company (MetLife)'s BCEL Position: Q2 2021 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2021, closing a stake of 7,987 shares — an estimated $122K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BCEL in Q1 2020 and held it in 5 quarters. The position peaked at $145K in Q4 2020. 108 funds tracked by Wall St. Rank hold BCEL as of Q2 2021.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 7,987 Atreca, Inc. Class A Common Stock shares in Q2 2021, an estimated $122K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Atreca, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Atreca, Inc. Class A Common Stock position peaked at $145K in Q4 2020.
- 108 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2021.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.